Terms: = Uterine cancer AND RUNX1T1, ENSG00000079102, 862 AND Treatment
16 results:
1. Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer.
Kong W; Tu Y; Jiang P; Huang Y; Zhang J; Jiang S; Li N; Yuan R
Int J Biol Markers; 2022 Dec; 37(4):395-403. PubMed ID: 36250543
[TBL] [Abstract] [Full Text] [Related]
2. Use of Nomogram to Predict the Risk of Lymph Node Metastasis among Patients with Cervical Adenocarcinoma.
Tian Y; Hao Y; Liu Q; Li R; Mao Z; Jiang N; Wang B; Zhang W; Zhang X; Cui B
J Immunol Res; 2022; 2022():6816456. PubMed ID: 36052281
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and validation of prognostic nomograms integrating histopathological features in patients with endocervical adenocarcinoma.
Luo RZ; Yang X; Zhang SW; Liu LL
J Clin Pathol; 2023 Nov; 76(11):747-752. PubMed ID: 35999033
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of the Viability of Untreated Leiomyomas Using Computed Tomography-Detected Calcification Patterns.
Crane EP; Fenlon EP; Ascher SM; Balaji D; Siegelman ES
J Comput Assist Tomogr; 2022 Jan-Feb 01; 46(1):6-10. PubMed ID: 35099130
[TBL] [Abstract] [Full Text] [Related]
5. Rates of Low-Value Service in Australian Public Hospitals and the Association With Patient Insurance Status.
de Oliveira Costa J; Pearson SA; Elshaug AG; van Gool K; Jorm LR; Falster MO
JAMA Netw Open; 2021 Dec; 4(12):e2138543. PubMed ID: 34889943
[TBL] [Abstract] [Full Text] [Related]
6. Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients.
Qin J; Zhang S; Poon L; Pan Z; Luo J; Yu N; Wang L; Wu X; Cheng X; Xie X; Lu Y; Lu W
Ultrasound Obstet Gynecol; 2021 May; 57(5):829-839. PubMed ID: 32385928
[TBL] [Abstract] [Full Text] [Related]
7. A Systematic Review of Tests for Postcolposcopy and Posttreatment Surveillance.
Clarke MA; Unger ER; Zuna R; Nelson E; Darragh TM; Cremer M; Stockdale CK; Einstein MH; Wentzensen N
J Low Genit Tract Dis; 2020 Apr; 24(2):148-156. PubMed ID: 32243310
[TBL] [Abstract] [Full Text] [Related]
8. Prevalence of venous thromboembolism at pretreatment screening and associated risk factors in 2086 patients with gynecological cancer.
Tasaka N; Minaguchi T; Hosokawa Y; Takao W; Itagaki H; Nishida K; Akiyama A; Shikama A; Ochi H; Satoh T
J Obstet Gynaecol Res; 2020 May; 46(5):765-773. PubMed ID: 32147891
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics and prognostic features of intravenous leiomyomatosis with inferior vena cava or intracardiac extension.
Zhang G; Yu X; Shi H; Fan Q; Lang J; Liu B
J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):485-492. PubMed ID: 28623982
[TBL] [Abstract] [Full Text] [Related]
10. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
11. Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-Grade Cervical Dysplasia and Cervical cancer in Rheumatoid Arthritis: A Cohort Study.
Kim SC; Schneeweiss S; Liu J; Karlson EW; Katz JN; Feldman S; Solomon DH
Arthritis Rheumatol; 2016 Sep; 68(9):2106-13. PubMed ID: 27015113
[TBL] [Abstract] [Full Text] [Related]
12. Impact of gene dosage on gene expression, biological processes and survival in cervical cancer: a genome-wide follow-up study.
Medina-Martinez I; Barrón V; Roman-Bassaure E; Juárez-Torres E; Guardado-Estrada M; Espinosa AM; Bermudez M; Fernández F; Venegas-Vega C; Orozco L; Zenteno E; Kofman S; Berumen J
PLoS One; 2014; 9(5):e97842. PubMed ID: 24879114
[TBL] [Abstract] [Full Text] [Related]
13. Intra-patient comparison between two annular phased array applicators, Sigma-60 and Sigma-Eye: Applied RF powers and intraluminally measured temperatures.
Fatehi D; van der Zee J; van Rhoon GC
Int J Hyperthermia; 2011; 27(3):214-23. PubMed ID: 21405984
[TBL] [Abstract] [Full Text] [Related]
14. [Invasive cervical cancer treatment costs in France].
Arveux P; Bénard S; Bouée S; Lafuma A; Martin L; Cravello L; Rémy V; Breugelmans JG
Bull Cancer; 2007 Feb; 94(2):219-24. PubMed ID: 17337390
[TBL] [Abstract] [Full Text] [Related]
15. The health care costs of cervical human papillomavirus--related disease.
Insinga RP; Glass AG; Rush BB
Am J Obstet Gynecol; 2004 Jul; 191(1):114-20. PubMed ID: 15295351
[TBL] [Abstract] [Full Text] [Related]
16. Cervical carcinoma in women less than 35 years of age.
Austin JP; Degefu S; Torres J; Bush DJ; O'Quinn AG; Ozmen N; Rice J
South Med J; 1994 Mar; 87(3):375-9. PubMed ID: 8134861
[TBL] [Abstract] [Full Text] [Related]
